0001213900-21-040572.txt : 20210805
0001213900-21-040572.hdr.sgml : 20210805
20210805171806
ACCESSION NUMBER: 0001213900-21-040572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210804
FILED AS OF DATE: 20210805
DATE AS OF CHANGE: 20210805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeLuca Teresa
CENTRAL INDEX KEY: 0001685627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 211149527
MAIL ADDRESS:
STREET 1: 40 BURTON HILLS BOULEVARD, SUITE 500
CITY: NASHVILLE
STATE: TN
ZIP: 37215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
X0306
4
2021-08-04
0
0001690080
180 Life Sciences Corp.
ATNF
0001685627
DeLuca Teresa
3000 EL CAMINO REAL
BLDG. 4, SUITE 200
PALO ALTO
CA
94306
1
0
0
0
Common Stock
0
D
Non-Qualified Stock Option (right to buy)
7.56
2021-08-04
4
A
0
79000
0.0
A
2031-08-04
Common Stock
79000
79000
D
Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated under the Exchange Act.
The Options vest at the rate of 1/48th of such options ratably on a monthly basis over the following 48 months following the grant date, on the last day of each calendar month (beginning on August 31, 2021), subject to the holder's continued service to the Company.
/s/ Teresa DeLuca
2021-08-05